Testing effectiveness (Phase 2)Not Yet RecruitingNCT04016129What this trial is testingCAR-T Immunotherapy Targeting CD19- ALLWho this might be right forB-cell Leukemia Shenzhen Geno-Immune Medical Institute 100
Testing effectiveness (Phase 2)UnknownNCT06503094What this trial is testingCD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological TumorsWho this might be right forB-Cell Lymphoblastic Leukemia/Lymphoma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 80
Very early researchNot Yet RecruitingNCT06298266What this trial is testingTo Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multiple MyelomaWho this might be right forRelapsed or Refractory Multiple Myeloma Guangdong Second Provincial General Hospital 15
Early research (Phase 1)WithdrawnNCT06290622What this trial is testingPD-1, LAG-3 and TIM-3 Checkpoint Blockade in DLBCLWho this might be right forDiffuse Large B Cell LymphomaLymphoma, B-CellLymphoma, Follicular University of Alabama at Birmingham
Early research (Phase 1)UnknownNCT05487651What this trial is testingAllogeneic NK T-Cells Expressing CD19 Specific CAR in B-Cell MalignanciesWho this might be right forNHL, Relapsed, AdultB-cell LymphomaB-cell Leukemia+4 more Athenex, Inc. 36
Very early researchUnknownNCT04156269What this trial is testingBCMA-CS1 Compound CAR (cCAR) T Cells for Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple Myeloma iCell Gene Therapeutics 12
Very early researchNot Yet RecruitingNCT07335094What this trial is testingA Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive ChemotherapyWho this might be right forB Lymphoblastic Leukemia/Lymphoma Zhujiang Hospital 60
Early research (Phase 1)Study completedNCT00275080What this trial is testingVorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+48 more National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00006379What this trial is testingNon-Ablative Allo HSCT For Hematologic Malignancies or SAAWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT01529827What this trial is testingFludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more Roswell Park Cancer Institute 94
Early research (Phase 1)Study completedNCT00058812What this trial is testingGiving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow GraftsWho this might be right forEpstein-Barr Virus Infections Baylor College of Medicine 69
Not applicableWithdrawnNCT00770419What this trial is testingPerceptions of Burden in Patients With Late-Stage Cancer and Their CaregiversWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersDepression+7 more Rutgers, The State University of New Jersey
Very early researchStudy completedNCT02846935What this trial is testingP53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Refractory/Relapsed Lymphoid MalignanciesWho this might be right forT-cell LymphomaAggressive B-cell LymphomaNon-Hodgkin's Lymphomas+1 more Yogen Saunthararajah 7
Early research (Phase 1)Looking for participantsNCT06208735What this trial is testingCLIC-2201 for the Treatment of Relapsed/Refractory B Cell MalignanciesWho this might be right forB-Cell LeukemiaNon-Hodgkin's LymphomaB-cell Acute Lymphoblastic Leukemia+5 more British Columbia Cancer Agency 24
Testing effectiveness (Phase 2)UnknownNCT02537977What this trial is testingCD19-directed CAR T Cells Therapy in Relapsed/Refractory B Cell MalignancyWho this might be right forLeukemiaLymphoma Shanghai Tongji Hospital, Tongji University School of Medicine 60
Not applicableUnknownNCT05772728What this trial is testingChidamide Combined With Azacitidine and Mitoxantrone Liposome in the Treatment of Relapsed/Refractory (nTFHL)Who this might be right forT Cell Lymphoma The First Affiliated Hospital with Nanjing Medical University 23
Testing effectiveness (Phase 2)UnknownNCT04648475What this trial is testingSafety and Efficacy of CD19 and CD22 Targeted CAR-T Therapy for Relapsed/Refractory B Cell Leukemia and LymphomaWho this might be right forLeukemia, B-cellLymphoma, B-Cell Chongqing Precision Biotech Co., Ltd 40
Testing effectiveness (Phase 2)Looking for participantsNCT06918912What this trial is testingStudy of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy FailureWho this might be right forDiffuse Large B-Cell LymphomaHigh-grade B-cell Lymphoma (HGBCL)B-Cell Lymphoma Treatment+1 more Istituto Clinico Humanitas 50
Not applicableEnded earlyNCT00726830What this trial is testingMethadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more M.D. Anderson Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT07013565What this trial is testingChemoimmunotherapy for ALK+ Relapsed/Refractory ALCLWho this might be right forAnaplastic Large Cell Lymphoma, ALK-Positive New York Medical College 20